These 3 Aussie stocks could skyrocket and stay there for decades

Let's see what sets these stocks apart from the rest.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points
  • CSL Ltd, a biotechnology leader with a robust plasma collection network and extensive R&D investment, offers high barriers to entry and future growth prospects despite recent share price pressure.
  • Pro Medicus, known for its Visage medical imaging platform, enjoys high margins and growth potential with sticky recurring revenues from long-term U.S. contracts, positioned to benefit from global healthcare digitization.
  • WiseTech Global, with its indispensable CargoWise platform in logistics, maintains a dominant market position with high switching costs and is poised for long-term growth through global trade expansion and strategic acquisitions.

Every now and then, the ASX delivers stocks with the potential not only to climb higher but to keep delivering for shareholders long after the initial run-up.

These are the kinds of businesses with strong competitive advantages, huge global markets, and management teams that know how to execute.

Let's now look at three Aussie stocks that tick these boxes and could be destined to skyrocket — and stay there for decades.

A woman wearing dark clothing and sporting a few tattoos and piercings holds a phone and a takeaway coffee cup as she strolls under the Sydney Harbour Bridge which looms in the background.

Image source: Getty Images

CSL Ltd (ASX: CSL)

CSL is a biotechnology giant that has turned into one of Australia's greatest corporate success stories. With its plasma therapies, vaccines, and specialty treatments, this Aussie stock has built a global footprint that few rivals can match.

What makes CSL so attractive for long-term investors is its moat. The company operates one of the world's largest plasma collection networks and reinvests heavily into research and development each year. This combination creates high barriers to entry and a pipeline of new treatments to fuel future growth.

While its share price has been under pressure recently, history suggests that CSL has the resilience and the innovation to keep compounding earnings well into the future.

Pro Medicus Ltd (ASX: PME)

Another Aussie stock to look at is Pro Medicus. It is a medical imaging software provider that's taking the healthcare world by storm. Its Visage platform allows hospitals and radiologists to view, share, and analyse images faster and more efficiently than traditional systems.

Once installed, Visage generates sticky recurring revenues from long-term contracts, particularly in the U.S. healthcare system. With major hospitals already on board and new deals being signed, Pro Medicus has plenty of room to grow.

Its margins are among the best on the ASX, and with the digitisation of healthcare accelerating globally, Pro Medicus could remain a top performer for decades.

WiseTech Global Ltd (ASX: WTC)

Finally, WiseTech Global has become an indispensable player in the logistics industry. The Aussie stock's CargoWise platform is used worldwide by freight forwarders, customs brokers, and transport companies to manage supply chains.

The company has carved out a dominant position by offering a single, integrated solution that replaces clunky, outdated systems. Its customer base is sticky, with high switching costs that make it difficult for rivals to compete.

With global trade volumes expected to keep rising and WiseTech expanding its product suite with acquisitions, its long-term growth potential is enormous. For investors, it could be a classic example of an ASX tech company with global scalability.

Motley Fool contributor James Mickleboro has positions in CSL, Pro Medicus, and WiseTech Global. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended CSL and WiseTech Global. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has positions in and has recommended WiseTech Global. The Motley Fool Australia has recommended CSL and Pro Medicus. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Growth Shares

Man drawing an upward line on a bar graph symbolising a rising share price.
Growth Shares

A rare buying opportunity in 1 of Australia's top shares?

Growth investors will not want to miss this exciting share.

Read more »

Three happy office workers cheer as they read about good financial news on a laptop.
Growth Shares

Are these the best ASX growth shares to buy and hold for 10 years?

Brokers rate these growth shares as buys in April. Here's what you need to know.

Read more »

A young man talks tech on his phone while looking at a laptop with a financial graph superimposed across the image.
Growth Shares

3 ASX growth shares to buy with $10,000

Looking to add some growth shares to your portfolio? Here are three that brokers rate as buys.

Read more »

Two smiling work colleagues discuss an investment at their office.
Growth Shares

3 ASX 300 shares that could be much bigger in 5 years

Big returns could be on offer from these shares according to analysts.

Read more »

Two brokers analysing the share price with the woman pointing at the screen and man talking on a phone.
Growth Shares

3 ASX shares tipped to grow 75% or more in the next 12 month!

These businesses may be significantly undervalued.

Read more »

A woman looks excited as she holds Australian dollars in the air.
Growth Shares

2 undervalued ASX shares to buy that experts think could deliver strong returns

A fund manager thinks these ASX shares could deliver great returns.

Read more »

A young man punches the air in delight as he reacts to great news on his mobile phone.
Growth Shares

5 ASX growth shares to buy and hold for 5 years

These shares could be destined for bright futures.

Read more »

A woman with a magnifying glass adjusts her glasses as she holds the glass to her computer screen and peers closely at it.
Growth Shares

3 ASX shares below $5 with huge potential

Some of the most interesting ASX shares are not the biggest, but those still early in their growth journey.

Read more »